Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 66:12)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004095 AN006788 Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics Cultured cells Human Cancer Amgen LC-MS
ST003090 AN005054 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST002843 AN004653 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) Liver Mouse Cancer Rutgers University LC-MS
ST002842 AN004651 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) Liver Mouse Cancer Rutgers University LC-MS
ST002729 AN004426 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University LC-MS
ST000669 AN001025 Characterization of Retinal Exudates in Coats Disease - lipid profile Eye tissue Human Eye disease University of Michigan LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo